Skip to content

Dolutegravir-based ART recommended for all – if reliable contraception is available

Women at the dolutegravir demonstration at AIDS 2018. ©International AIDS Society/Marten van Dijl

Dolutegravir may cause birth defects, European Medicines Agency warns

What are the outcomes for adults who were born with HIV?

Caroline Foster presenting at the 2018 BHIVA/BASHH conference. Image credit: @erica_pool

HIV-positive women starting antiretrovirals before conception have increased risk of having an infant that is small for gestational age

Stillbirth more frequent in women with HIV in UK and Ireland than in general population

Graziella Favarato at IAS 2017. Image credit: Dr Heather Bailey (@DrHeatherBailey)

Adolescents with HIV do better in more prosperous African countries, even with treatment

Presenter Amy Slogrove with IAS President Linda-Gail Bekker at IAS 2017. Photo by Marcus Rose/IAS

Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Rebecca Zash at IAS 2017. Photo by Steve Forrest/Workers' Photos/IAS

No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

People shifting from paediatric to adult HIV care have a high risk of ART failure